December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
According to market projections, the U.S. healthcare CRM sector is expected to grow from USD 9.92 million in 2024 to USD 19.94 million by 2034, reflecting a CAGR of 7.23%. In 2024, the U.S. healthcare CRM market was dominated by the software segment. The service segment is set for significant growth, while the sales functionality led the market and...
November 01, 2025
Market insights predict the global biologics CDMO industry will increase from USD 22 billion in 2024 to USD 92.79 billion by 2034, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is expected to grow fastest. Mammalian types dominated, while microbial types are set to expand. Monoclonal a...
November 01, 2025
According to market projections, the global U.S. concierge medicine market, valued at USD 7.25 billion in 2024, is anticipated to reach USD 19.36 billion by 2034, growing at a CAGR of 10.36% over the next decade. In 2024, the group segment dominated the U.S. concierge medicine market by ownership, while the standalone segment is set to grow at the ...
November 01, 2025
Forecasts suggest that the nootropics market will expand from USD 4.98 billion in 2024 to USD 19.53 billion by 2034, with a CAGR of 14.64% during this period. In 2024, North America led the nootropics market, while Asia Pacific is set for the fastest growth. Capsules/tablets dominated by form, but drinks will grow the quickest. Offline channels led...
November 01, 2025
Market insights predict the global cell dissociation industry will increase from USD 406.36 million in 2024 to USD 1451.89 million by 2034, achieving a CAGR of 13.58%. In 2024, North America led the cell dissociation market with a 38% share, while Asia Pacific is set for the fastest growth. Enzymatic dissociation dominated by product, but non-enzym...
November 01, 2025
According to market projections, the preclinical CRO sector is expected to grow from USD 6.25 billion in 2024 to USD 14.34 billion by 2034, reflecting a CAGR of 8.73%. In 2024, North America led the preclinical CRO market with a 48% share, while Asia Pacific is set for the fastest growth through 2034. Toxicology testing dominated by service, while ...
November 01, 2025
Market insights predict the global industrial microbiology industry will increase from USD 12.75 billion in 2024 to USD 24.92 billion by 2034, achieving a CAGR of 6.93%. In 2024, North America led the industrial microbiology market with a 47% share, while Asia Pacific is set for the fastest growth. Reaction consumables dominated by product, but equ...
November 01, 2025
The global cell culture media market, valued at USD 6.9 billion in 2024, is anticipated to reach USD 20.32 billion by 2034, growing at a CAGR of 11.45% over the next decade. In 2024, North America led the global cell culture media market, while Asia-Pacific is set for the fastest growth. Liquid media and serum-free media held the largest shares. Bi...
November 01, 2025
According to market projections, the clinical trial biorepository and archiving solutions sector is expected to grow from USD 4.4 billion in 2024 to USD 9.69 billion by 2034, reflecting a CAGR of 8.21%. In 2024, North America led the clinical trial biorepository and archiving solutions market with a 49% share, while Asia Pacific is set for the fast...
November 01, 2025
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseas...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com